Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen.

@article{Shohin2012BiowaiverMF,
  title={Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen.},
  author={Igor E. Shohin and Julia I Kulinich and Galina Vladislavovna Ramenskaya and Bertil Abrahamsson and Sabine Kopp and Peter Langguth and James E. Polli and Vinod P. Shah and Dirk W Groot and Dirk M. Barends and Jennifer Boehm Dressman},
  journal={Journal of pharmaceutical sciences},
  year={2012},
  volume={101 10},
  pages={
          3593-603
        }
}
  • Igor E. Shohin, Julia I Kulinich, +8 authors Jennifer Boehm Dressman
  • Published 2012
  • Medicine, Chemistry
  • Journal of pharmaceutical sciences
  • Literature and experimental data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate-release (IR) solid oral dosage forms containing ketoprofen are reviewed. Ketoprofen's solubility and permeability, its therapeutic use and therapeutic index, pharmacokinetic properties, data related to the possibility of excipient interactions, and reported BE/bioavailability (BA)/dissolution data were taken into consideration. The available data… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 51 CITATIONS, ESTIMATED 52% COVERAGE

    Biowaiver monograph for ascorbic acid immediate release solid oral dosage forms

    VIEW 3 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Interactions between active pharmaceutical ingredients and excipients affecting bioavailability: impact on bioequivalence.

    • Alfredo García-Arieta
    • Medicine, Chemistry
    • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
    • 2014

    Evaluating bioequivalence of meloxicam tablets: is in‐vitro dissolution test overdiscriminating?

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects

    VIEW 1 EXCERPT
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    2013
    2020

    CITATION STATISTICS

    • 2 Highly Influenced Citations

    • Averaged 6 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 85 REFERENCES

    Biowaivers for Oral Immediate-Release Products